You are viewing: Spain Veterinary Contract Manufacturing & Research Market analysis

The Spain Veterinary Contract Manufacturing & Research Market was valued at $31 Million in 2026 and projected to reach to $41.8 Million by 2031, representing a compound annual growth rate of 6.2%. Spain's veterinary contract manufacturing and research sector is experiencing steady growth, driven by increasing demand for outsourced pharmaceutical development and the country's competitive advantages within the European market.

Spain Veterinary Contract Manufacturing & Research Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Spain Veterinary Contract Manufacturing & Research Market Trends and Insights

  • This growth trajectory reflects Spain's strengthening position within Europe's veterinary pharmaceutical and biologics outsourcing sector.
  • Spain benefits from established regulatory frameworks, skilled workforce capabilities, and proximity to major European markets, positioning the country as a reliable hub for contract research and manufacturing services tailored to veterinary applications. The Spanish market is driven by increasing demand for specialized veterinary pharmaceuticals, rising pet ownership, and growing livestock health management requirements across the Iberian Peninsula and broader European markets.
  • Spain's veterinary contract manufacturing sector supports both domestic and international clients seeking cost-effective, compliant production and research solutions.
  • Between 2026 and 2031, Spain is expected to capture growing market share as European veterinary companies seek nearshoring opportunities and regulatory-compliant manufacturing partners..

Key Market Statistics

  • CAGR (2026-2031) 6.2% CAGR
  • Market Size, 2026 ~USD 31 Million
  • Forecast, 2031 ~USD 41.8 Million
  • Country Spain

Spain Veterinary Contract Manufacturing & Research Market Overview

Market Valuation Growth :

Spain's veterinary contract manufacturing and research market is valued at $31.0 million in 2026, with projections reaching $41.8 million by 2031, demonstrating robust expansion at a 6.2% CAGR.

Regulatory Advantage :

Spain benefits from established EU regulatory frameworks and compliance standards that facilitate veterinary pharmaceutical development and manufacturing, positioning it as a trusted outsourcing destination.

Skilled Workforce :

Spain possesses a well-trained workforce in pharmaceutical sciences and veterinary research, supported by strong educational institutions and research centers specializing in animal health solutions.

European Market Access :

As an EU member, Spain provides strategic access to broader European veterinary markets, enabling contract manufacturers to serve multinational pharmaceutical companies across the continent.

Spain Veterinary Contract Manufacturing & Research Market Dynamics

  • The 6.2% CAGR reflects growing investments in animal health innovation and the expansion of contract research organizations (CROs) specializing in veterinary applications. Looking ahead, Spain is positioned to capture greater market share through enhanced infrastructure development, strategic partnerships with international pharmaceutical firms, and continued investment in research capabilities.
  • The country's alignment with EU regulatory standards and its skilled talent pool will continue to attract multinational companies seeking reliable outsourcing partners for veterinary drug development and manufacturing..

Related Ecosystem

Animal Health

Top Technologies
    Top Companies

      Key Takeaways

      • Spain's veterinary contract manufacturing & research market is valued at $31.0M in 2026 and forecast to reach $41.8M by 2031, growing at 6.2% CAGR.
      • Spain's strategic location, regulatory compliance infrastructure, and skilled workforce position it as a key European hub for veterinary outsourcing services.
      • Rising pet ownership and livestock health management demand across Spain and neighboring markets drive contract manufacturing growth through 2031.
      • Spain attracts international veterinary pharmaceutical companies seeking nearshoring and cost-effective, compliant manufacturing and research partnerships.

      Veterinary Contract Manufacturing & Research Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment CDMO SERVICES (Service)
      Forecast Period 2026–2031
      Growth Rate CAGR of 7.7% from 2026 to 2031
      Largest Segment CDMO SERVICES (Service)
      Market Size Base Year (Billions) ~USD 6.38 (2026)
      Revenue Forecast (Billions) ~USD 9.24 (2031)
      Segments Covered Service, Type

      Spain Veterinary Contract Manufacturing & Research Market Report Segmentation

      2 segment dimensions are covered across the global market.

      By Service

      • Cdmo Services
      • Cro Services

      By Type

      • Analytical & Bioanalytical Services And Quality Assurance
      • Discovery & Pre-Clinical Studies
      • Manufacturing
      • Packaging & Labeling
      • Process Api & Formulation Development
      • Quality/Stability & Post-Market Support
      • Regulatory Affairs & Consulting
      • Veterinary Clinical Trials

      SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031

      Segment20242025202620272028202920302031CAGR (%)
      MID-SIZED/SPECIALTY ANIMAL HEALTH FIRMS12.112.813.614.515.416.417.518.66.5
      MULTINATIONAL ANIMAL HEALTH COMPANIES11.211.712.212.813.313.914.615.24.5
      START-UPS & VETERINARY BIOTECH FIRMS4.44.75.25.66.16.77.37.99
      TOTAL27.629.23132.934.937.139.441.86.2

      Target Audience

      • Pharmaceutical Companies : Multinational and regional veterinary pharmaceutical firms seeking reliable contract manufacturing and research partners in Spain to optimize development timelines and reduce operational costs.
      • Contract Research Organizations (CROs) : Existing and emerging CROs need market intelligence on Spain's veterinary research landscape to identify expansion opportunities, competitive positioning, and client acquisition strategies.
      • Investment & Private Equity Firms : Investors evaluating opportunities in Spain's veterinary healthcare sector require market sizing, growth projections, and competitive dynamics to assess acquisition and funding targets.
      • Government & Trade Organizations : Spanish economic development agencies and industry associations need market data to support policy initiatives, attract foreign investment, and promote the country's veterinary manufacturing capabilities.
      • Veterinary Biotech Startups : Emerging animal health companies require insights into Spain's outsourcing ecosystem, regulatory pathways, and manufacturing capabilities to plan product development and commercialization strategies.

      Reasons to Buy this Report

      • Market Size & Growth Projections : Access detailed valuation data showing Spain's market growing from $31.0M to $41.8M (2026-2031), enabling accurate forecasting and investment planning for veterinary contract services.
      • Competitive Landscape Analysis : Understand Spain's positioning within Europe's veterinary outsourcing sector, identifying key competitors, market consolidation trends, and opportunities for service differentiation.
      • Regulatory & Compliance Insights : Gain comprehensive knowledge of Spain's EU regulatory framework, quality standards, and compliance requirements specific to veterinary pharmaceutical manufacturing and research operations.
      • Strategic Partnership Opportunities : Identify potential collaboration partners, contract manufacturers, and research institutions in Spain to establish outsourcing relationships or expand existing veterinary service portfolios.
      • Investment Decision Support : Make informed decisions about market entry, facility expansion, or acquisition strategies in Spain's growing veterinary contract manufacturing sector with validated market intelligence.

      Frequently asked questions

      What is the current market size of veterinary contract manufacturing in Spain?

      Spain's veterinary contract manufacturing and research market is valued at $31.0 million in 2026.

      What is the projected market size for Spain's veterinary contract manufacturing sector by 2031?

      Spain's veterinary contract manufacturing and research market is forecast to reach $41.8 million by 2031.

      What is the growth rate (CAGR) for Spain's veterinary contract manufacturing market?

      Spain's veterinary contract manufacturing and research market is expected to grow at a compound annual growth rate of 6.2% from 2026 to 2031.

      Why is Spain an attractive location for veterinary contract manufacturing?

      Spain offers established regulatory frameworks, skilled workforce capabilities, proximity to major European markets, and cost-effective production solutions that appeal to international veterinary pharmaceutical companies.

      What factors are driving growth in Spain's veterinary contract manufacturing market?

      Key drivers include rising pet ownership, increasing livestock health management requirements, growing demand for specialized veterinary pharmaceuticals, and European companies seeking nearshoring and compliant manufacturing partners.

      RESEARCH METHODOLOGY

      This research study extensively utilized both primary and secondary sources. It involved analyzing various factors that influence the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and the strategies employed by key players.

      Secondary Research

      This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary contract manufacturing & research market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments about both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

      Primary Research

      In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development, and operations managers, as well as presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary contract manufacturing & research market. Primary sources from the demand side include R&D scientists and researchers in animal health companies, veterinary clinicians, and veterinary biotech firms developing veterinary therapeutics and technologies.

      Veterinary Contract Manufacturing and Research Market 
 Size, and Share

      Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
      Note 2: Other designations include sales, marketing, and product/service managers.

      Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The total size of the veterinary contract manufacturing & research market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

      Veterinary Contract Manufacturing and Research Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the veterinary contract manufacturing & research market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and obtain precise statistics for all segments and subsegments.

      Market Definition

      The veterinary contract research organization (CRO) market comprises third-party service providers that support animal-health companies in the outsourced research and development of veterinary pharmaceuticals, biologics, vaccines, and related products. Veterinary CROs provide services across the product lifecycle, including discovery support, preclinical studies, target animal safety, clinical field trials, bioequivalence studies, regulatory consulting, and post-approval research, in compliance with veterinary regulatory standards. These services are primarily used by animal-health pharmaceutical companies, biotechnology firms, and vaccine developers to reduce development timelines, access specialized expertise, manage regulatory complexity, and optimize R&D costs without maintaining a complete in-house research infrastructure. The veterinary contract development and manufacturing organization (CDMO) market consists of third-party manufacturers that provide outsourced development, scale-up, and commercial manufacturing services for veterinary drugs, biologics, vaccines, and related products. Veterinary CDMOs support animal-health companies through process and formulation development, API and finished dosage form manufacturing, fill-finish operations, packaging and labeling, quality control, stability testing, and regulatory manufacturing support, operating in accordance with veterinary GMP and biologics regulations.

      These services enable animal-health companies to outsource capital-intensive manufacturing activities, increase production flexibility, manage capacity constraints, and accelerate market entry, particularly for complex formulations, sterile injectables, and veterinary vaccines.

      Key Stakeholders

      • Animal-health pharmaceutical companies
      • Veterinary biotechnology companies
      • Veterinary biologics & vaccine developers
      • Veterinary contract development & manufacturing organizations (CDMOs)
      • Veterinary contract research organizations (CROs)
      • Preclinical & toxicology research laboratories (GLP & non-GLP)
      • Clinical trial management organizations for veterinary studies
      • Regulatory consulting firms specializing in VICH / EMA / FDA-CVM
      • Quality control & analytical testing laboratories (veterinary-focused)
      • Veterinary formulation & process development service providers
      • Packaging, filling, and labeling service providers for veterinary products
      • Animal research facilities & field trial centers
      • Veterinary academic research institutes
      • Livestock research institutions & herd-health trial networks
      • Raw material suppliers for veterinary APIs, excipients, and biologics components

      Report Objectives

      • To define, describe, segment, and forecast the veterinary contract manufacturing & research market by service, product type, animal type, end user, and region
      • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall veterinary contract manufacturing & research market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the veterinary contract manufacturing & research market in five central regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players in the veterinary contract manufacturing & research market and comprehensively analyze their core competencies and market shares
      • To track and analyze competitive developments such as acquisitions, service launches, expansions, collaborations, agreements, and partnerships

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

      Company Information
      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe veterinary contract manufacturing & research market into Austria, Finland, Switzerland, and other countries
      • Further breakdown of the Rest of Latin American veterinary contract manufacturing & research market into Colombia, Chile, and other countries
      Competitive Landscape Assessment
      • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the veterinary contract manufacturing & research market
      • Competitive leadership mapping for established players in the US

       

      Get the Full Veterinary Contract Manufacturing & Research Market Report

      Full forecast, segment splits, and company analysis for all Veterinary Contract Manufacturing & Research Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status